The British Journal of Psychiatry (2009) 194: 313-318. doi: 10.1192/bjp.bp.108.050401
© 2009 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data supplement
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lencz, T.
Right arrow Articles by Malhotra, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lencz, T.
Right arrow Articles by Malhotra, A. K.

Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes

Todd Lencz, PhD

Center for Translational Psychiatry, Feinstein Institute for Medical Research and Division of Psychiatry Research, The Zucker Hillside Hospital, New York

Robert H. Lipsky, PhD

Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda

Pamela DeRosse, PhD

Division of Psychiatry Research, The Zucker Hillside Hospital

Katherine E. Burdick, PhD

Center for Translational Psychiatry, Feinstein Institute for Medical Research and Division of Psychiatry Research, The Zucker Hillside Hospital, New York

John M. Kane, MD

Center for Translational Psychiatry, Feinstein Institute for Medical Research and Department of Psychiatry, The Zucker Hillside Hospital

Anil K. Malhotra, MD

Center for Translational Psychiatry, Feinstein Institute for Medical Research and Division of Psychiatry Research, The Zucker Hillside Hospital, New York, USA.

Correspondence: Todd Lencz, The Zucker Hillside Hospital, Psychiatry Research, 75–59 263rd Street, Glen Oaks, New York 11004, USA. Email: lencz{at}lij.edu

Declaration of interest

None.

Funding

This work was supported by the following grants from the National Institute of Mental Health: K01 MH65580 (T.L.), P30 MH60575 (J.M.K.), K23 MH01760 (A.K.M.), and a General Clinical Research Center (M01 RR18535) to the North Shore – Long Island Jewish Health System. This work was also supported by the National Alliance for Research on Schizophrenia and Depression (T.L. and A.K.M.).

Background

Allelic variation in the gene encoding brain-derived neurotrophic factor (BDNF) has been associated with affective disorders, but generally not schizophrenia. Brain-derived neurotrophic factor variants may help clarify the status of schizoaffective disorder.

Aims

To test the hypothesis that BDNF haplotypes are associated with psychiatric illness marked by a prominent affective component.

Method

Frequencies of a 5-marker BDNF haplotype were examined in 600 White participants across four diagnostic categories and healthy controls.

Results

Individuals with schizoaffective disorder and other affective disorders were significantly more likely to carry two copies of the most common BDNF haplotype (containing the valine allele of the Val66Met polymorphism) compared with healthy volunteers. Moreover, when compared with people with schizophrenia, individuals with schizoaffective disorder were significantly more likely to carry two copies of the common haplotype.

Conclusions

To our knowledge, this is the first candidate gene study to demonstrate association with schizoaffective disorder but not schizophrenia. Variation in the BDNF gene may be associated with the clinical phenotype of affective dysregulation across several DSM–IV diagnostic categories.


Related articles in BJP:

From the Editor’s desk
Peter Tyrer
BJP 2009 194: 386. [Full Text]  

Highlights of this issue
Kimberlie Dean
BJP 2009 194: A15. [Full Text]  



This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
T. J. Crow
BDNF Val66Met polymorphism and the affective component
The British Journal of Psychiatry, August 1, 2009; 195(2): 179 - 179.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
P. Tyrer
From the Editor's desk
The British Journal of Psychiatry, July 1, 2009; 195(1): 96 - 96.
[Full Text] [PDF]

eLetters:

Read all eLetters

The BDNF Val66Met polymorphism and the affective component – another false positive?
Timothy J Crow
BJP Online, 13 May 2009 [Full text]
Response to Dr. Crow
Todd Lencz, et al.
BJP Online, 27 May 2009 [Full text]
Val66Met and Bipolar Disorder: suggestions from previous studies
Alvaro M. Dias
BJP Online, 3 Jun 2009 [Full text]
Response to Mr. Dias
Todd Lencz, et al.
BJP Online, 15 Jun 2009 [Full text]